Market Tracker

10/31 7:05pm ET

Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

12.94
Data as of Oct 31
 -0.26 / -1.97%
Today’s Change
2.62
Today|||52-Week Range
13.61
+285.12%
Year-to-Date

Today’s Trading

Previous close13.20
Today’s open13.57
Day’s range12.60 - 13.61
Volume8,451,810
Average volume (3 months)5,905,852
Market cap$2.5B
Dividend yield--
Data as of 4:14pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-17.78%
Earnings growth (this year)+46.79%
Earnings growth (next 5 years)+26.55%
Revenue growth (last year)+82.59%
P/E ratioNM
Price/Sales7.99
Price/Book108.67

Competitors

 Today’s
change
Today’s
% change
--Cosmo Pharmaceutical...-11.95-6.38%
MNKDMannkind Corp-0.07-1.15%
WXWuxi Pharmatech Caym...-0.05-0.13%
MYGNMyriad Genetics Inc+1.49+3.92%
Data as of 4:04pm ET, 10/31/2014

Financials

Next reporting dateNovember 25, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$75.4M
Annual profit (last year)-$75.5M
Net profit margin-100.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith A. Katkin
Secretary &
Vice President-Finance
Christine G. Ocampo
Corporate headquarters
Aliso Viejo, California

Forecasts